Evidence map›Paper›PMID 30666150›Full record

ArticleInternational journal of general medicine2019

Atrial fibrillation: risk factors and comorbidities in a tertiary center in Jeddah, Saudi Arabia.

Abdullah Abdulfattah Mashat, Ahmed Hussein Subki, Moaz Abdulrahman Bakhaider, Wejdan Mohammad Baabdullah, Jawaher Badr Walid, Abdulrahman Hatim Alobudi, Maged Mazen Fakeeh, Anas Jamal Algethmi, Wesam Awad Alhejily

Open access · goldAbstract read
In one paragraph

Article in International journal of general medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Observational
  4. Article
  5. Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Observational
  6. Article
  7. Article
  8. Article
  9. Impact of comorbid conditions on disease-specific quality of life in older men and women with atrial fibrillation.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Evaluation of the Clinical Outcomes of Apixaban Use in Patients with Atrial Fibrillation and Uncontrolled Hypothyroidism: A Real-world Evidence.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Abdullah Abdulfattah MashatDepartment of Internal Medicine, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia, walhejily@kau.edu.sa.
Ahmed Hussein SubkiDepartment of Internal Medicine, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia, walhejily@kau.edu.sa.
Moaz Abdulrahman BakhaiderDepartment of Internal Medicine, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia, walhejily@kau.edu.sa.
Wejdan Mohammad BaabdullahDepartment of Internal Medicine, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia, walhejily@kau.edu.sa.
Jawaher Badr WalidDepartment of Internal Medicine, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia, walhejily@kau.edu.sa.
Abdulrahman Hatim AlobudiDepartment of Internal Medicine, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia, walhejily@kau.edu.sa.
Maged Mazen FakeehDepartment of Internal Medicine, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia, walhejily@kau.edu.sa.
Anas Jamal AlgethmiDepartment of Internal Medicine, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia, walhejily@kau.edu.sa.
Wesam Awad AlhejilyDepartment of Internal Medicine, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia, walhejily@kau.edu.sa.
King Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAtrial fibrillation (AF) is the most common type of cardiac arrhythmia worldwide and carries significant risk of morbidity and mortality. The prevalence of AF is high in significant parts of the world, but not much is known from countries, such as Saudi Arabia.

aimsTo study the risk factors, etiologies, comorbidities, and outcome of AF in Saudi Arabia. PATIENTS AND

methodsA retrospective study was conducted in King Abdul-Aziz Hospital in Jeddah during the period 2010-2017. Data were collected from both the electronic-and paper-based medical records of patients with AF. The data included the demographic information, adverse lifestyle (smoking and obesity), cardiothoracic surgery, and comorbidities.

resultsA total of 167 patients were included in the analysis (43% were males). The mean age was 63.3±35 years and the mean body mass index was 28.8±83. Hypertension (HTN) was the most prevalent risk factor encountered (73.1%). This was followed by valvular heart disease, and type 2 diabetes mellitus (T2DM), which occurred in 58.7% and 53.3% of patients, respectively. Valvular heart disease was significantly associated with older age (

conclusionAF was more prevalent among females in Saudi Arabia. HTN, valvular heart disease, and T2DM were the most prevalent risk factors of AF in Saudi Arabia. Valvular heart disease was more prevalent among older patients and significantly associated with CAD. HTN, CAD, and CKD were the most significant risk factors for HF in patients with AF.

Indexed as

atrial fibrillationcomorbiditiescomplicationsJeddahrisk factorsSaudi Arabia

Identifiers

PMID30666150
PMCPMC6333319
OpenAlexW2909121267

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.